Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants
- PMID: 12856723
- DOI: 10.1023/a:1024012000009
Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants
Abstract
Cellular adherence and motility are processes that are controlled by focal adhesion assembly and disassembly. Consequently, the dynamics of focal adhesions regulate tumor cell metastasis and are influenced by the tyrosine phosphorylation state of paxillin. Metastatic LLC cells are more migratory and have reduced paxillin tyrosine phosphorylation as compared to nonmetastatic LLC cells. In nonmetastatic Lewis lung carcinoma (LLC) tumor cells, inhibition of the serine/threonine protein phosphatase-2A (PP-2A) activity results in increased motility that is associated with a reduction in the phosphotyrosine content of paxillin. Studies to determine if PP-2A can regulate protein tyrosine phosphatase activity showed that blocking PP-2A activity of nonmetastatic LLC-C8 tumor cells with okadaic acid reduces protein tyrosine phosphatase activity. Among the tyrosine phosphatases whose activity was inhibited upon PP-2A inhibition is Shp-2. In contrast, protein levels of Shp-2 are unaffected by PP-2A inhibition. While these results do not fully identify how inhibition of PP-2A results in tyrosine dephosphorylation of paxillin, they do demonstrate that PP-2A can link serine/threonine and tyrosine signaling pathways by regulating protein tyrosine phosphatases.
Similar articles
-
Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins.Int J Cancer. 2003 Jan 1;103(1):38-44. doi: 10.1002/ijc.10772. Int J Cancer. 2003. PMID: 12455051
-
Protein phosphatase-2A modulates the serine and tyrosine phosphorylation of paxillin in Lewis lung carcinoma tumor variants.Clin Exp Metastasis. 2002;19(5):409-15. doi: 10.1023/a:1016385027013. Clin Exp Metastasis. 2002. PMID: 12198769
-
Protein phosphatases-1 and -2A regulate tumor cell migration, invasion and cytoskeletal organization.Adv Exp Med Biol. 1997;407:311-8. doi: 10.1007/978-1-4899-1813-0_46. Adv Exp Med Biol. 1997. PMID: 9321969
-
Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.Structure. 1998 Mar 15;6(3):249-54. doi: 10.1016/s0969-2126(98)00027-6. Structure. 1998. PMID: 9551546 Review.
-
Protein tyrosine phosphatases: mechanisms of catalysis and regulation.Curr Opin Chem Biol. 1998 Oct;2(5):633-41. doi: 10.1016/s1367-5931(98)80095-1. Curr Opin Chem Biol. 1998. PMID: 9818190 Review.
Cited by
-
Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1).Biochemistry. 2011 May 31;50(21):4537-49. doi: 10.1021/bi101949t. Epub 2011 May 9. Biochemistry. 2011. PMID: 21528848 Free PMC article.
-
Paxillin comes of age.J Cell Sci. 2008 Aug 1;121(Pt 15):2435-44. doi: 10.1242/jcs.018044. J Cell Sci. 2008. PMID: 18650496 Free PMC article. Review.
-
Role of mTOR signaling in tumor cell motility, invasion and metastasis.Curr Protein Pept Sci. 2011 Feb;12(1):30-42. doi: 10.2174/138920311795659407. Curr Protein Pept Sci. 2011. PMID: 21190521 Free PMC article. Review.
-
Dictyostelium discoideum paxillin regulates actin-based processes.Protist. 2009 May;160(2):221-32. doi: 10.1016/j.protis.2008.09.005. Epub 2009 Feb 11. Protist. 2009. PMID: 19213599 Free PMC article.
-
mTOR signaling in cancer cell motility and tumor metastasis.Crit Rev Eukaryot Gene Expr. 2010;20(1):1-16. doi: 10.1615/critreveukargeneexpr.v20.i1.10. Crit Rev Eukaryot Gene Expr. 2010. PMID: 20528734 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous